Lashify’s Global Legal Campaign to Protect Eyelash Patents Highlights Broader IP Challenges in Beauty Industry

Lashify, a prominent name in the beauty industry, has embarked on a challenging international legal campaign to safeguard its intellectual property rights. Known for its innovative false eyelash technology favored by celebrities, Lashify has seen its patented designs and techniques under threat from competitors around the globe. This legal battle underscores the broader struggles faced…

Read More

Ypsomed Resolves Patent Litigation with Auto Injection Technologies Over Insulin Pen Devices in Texas Court Settlement

Ypsomed Holding AG, a Swiss medical technology company, has successfully settled a patent lawsuit in a Texas federal court involving allegations of patent infringement brought by Auto Injection Technologies LLC. The dispute centered around two patents originally developed by Sanofi-Aventis, which were later acquired by Auto Injection Technologies. These patents are key to the design…

Read More

HighLevel Inc.’s Legal Battle Highlights Concerns Over PTAB’s Procedural Changes and Due Process Rights

In a critical legal maneuver, HighLevel Inc. has presented an appeal to the U.S. Court of Appeals for the Federal Circuit, arguing that the Patent Trial and Appeal Board’s (PTAB) decision against allowing reviews after a patent’s invalidation by a district court breaches due process rights. This stemmed from PTAB’s recent pronouncement that post-district court…

Read More

Delaware Jury Awards $1.5 Million in SMS Marketing Patent Infringement Case, Reflecting Growing Complexity in Digital Marketing Sector

On September 2, 2025, a Delaware federal jury reached a decision awarding $1.5 million in damages in a patent infringement case revolving around short message service (SMS) marketing systems. This legal battle involved two companies, each claiming that the other violated its intellectual property rights. The outcome reflects the increasing complexity and competitiveness of the…

Read More

Federal Circuit to Hear VLSI’s Appeal in Dispute Over PTAB’s Procedural Grounds

VLSI Technology LLC is vehemently seeking a renewed opportunity to defend its patent against OpenSky Industries LLC. The matter has escalated to the U.S. Court of Appeals for the Federal Circuit, with VLSI asserting that OpenSky’s inter partes review (IPR) initiation was endorsed based on guidance that has now been rescinded. The [initial report](https://www.law360.com/ip/articles/2383256?utm_source=rss&utm_medium=rss&utm_campaign=section), published…

Read More

Federal Unions Sue Over Executive Order, Testing Trump Administration’s Labor Policies

In a significant legal development, unions representing thousands of employees from the U.S. Patent and Trademark Office and the National Weather Service have initiated a lawsuit challenging an executive order by President Donald Trump. This order aims to dismantle their existing collective bargaining agreements, sparking substantial concerns over labor rights and workforce conditions. The lawsuit…

Read More

Federal Circuit Judge Criticizes Patent Verdict Reduction Amid Legal Debate

In a recent session, the Federal Circuit judge expressed frustration over confusion surrounding a dramatically reduced patent infringement verdict. Initially set at $10 million against Intuitive Surgical Inc., the verdict was slashed to merely $1. This contentious situation emerged during oral arguments, as reported in discussions on Law360. The attorney for Rex Medical clashed with…

Read More

Delaware Jury Clears Exela Pharma in Patent Dispute with Nexus Pharmaceuticals

In a significant legal development, a Delaware federal jury has exonerated Exela Pharma Sciences from allegations of patent infringement brought by Nexus Pharmaceuticals. The lawsuit centered on Exela’s formulation used to address low blood pressure during anesthesia, which Nexus claimed infringed on its patents. The decision alleviates concerns for Exela regarding the potential financial and…

Read More

Pharmaceutical Industry Adjusts Patent Strategies Amid Heightened FTC Scrutiny to Ensure Competitive Marketplace

The pharmaceutical industry’s response to warnings from the Federal Trade Commission (FTC) regarding improper patent listings in the U.S. Food and Drug Administration’s Orange Book suggests a significant shift in strategy. Traditionally, big pharmaceutical companies have been aggressive in their patent filings, a tactic often criticized for delaying the entry of generic drugs and, consequently,…

Read More

Ilan Osovsky Joins Vor Bio as General Counsel Amid Strategic Expansion in Biotechnology Industry

Vor Bio, a prominent biotechnology firm specializing in hematologic cell therapies, has announced the appointment of Ilan Osovsky as its new General Counsel. Osovsky brings a wealth of industry experience to the role, having previously held significant positions at various leading life sciences companies. This strategic hire is expected to bolster Vor Bio’s legal team…

Read More

Navigating the AI Revolution in Patent Law: Balancing Innovation with Ethical Oversight

The integration of artificial intelligence (AI) into patent prosecution is reshaping the landscape of intellectual property law. While AI offers tools that can enhance efficiency and accuracy, its adoption necessitates careful consideration of ethical obligations and practical challenges. In April 2024, the United States Patent and Trademark Office (USPTO) issued guidance addressing the use of…

Read More

Weil, Gotshal & Manges Expands Los Angeles Tech Practice with IP Litigator Joseph Lee

Weil, Gotshal & Manges LLP has announced the addition of Joseph Lee to its Los Angeles-based technology practice, marking a significant enhancement of their intellectual property litigation capabilities. Lee, formerly a partner at Knobbe Martens, brings a wealth of experience in handling complex patent disputes across various sectors, including electronics, telecommunications, and computer technology. His…

Read More

Federal Circuit Upholds Prosecution Laches Doctrine, Impacting Future Patent Filings and Litigation Strategies

The Federal Circuit recently affirmed the application of the prosecution laches doctrine in rejecting inventor Gilbert Hyatt’s appeal. This decision maintains that excessive delays during the patent prosecution process can render a patent unenforceable, showcasing the judicial system’s stance on the importance of timely filing. Hyatt’s case revolves around several patent applications filed decades ago,…

Read More

Epic Games Challenges Patent Infringement Lawsuit in Federal Court Amidst Tech Industry Scrutiny

Epic Games Inc., creator of the immensely popular Fortnite, has moved to dismiss a lawsuit in a North Carolina federal court, arguing that the patent infringement claims brought against it lack specificity and are too abstract for legal standing. The controversy involves player-to-player messaging features within the game, which a California company alleges infringe on…

Read More

Federal Circuit Extends Judge Newman’s Suspension, Highlighting Judicial Accountability Concerns

In a decision that underscores ongoing tensions within the Federal Circuit, Judge Pauline Newman has had her suspension from the bench extended by another year. The decision, rendered unanimously by Newman’s 11 fellow judges, signals persistent concerns about her capacity to fulfill her judicial duties effectively. The court’s opinion offered no signs of reconciliation following…

Read More

USPTO’s “Settled Expectations” Approach Sparks Debate in Patent Litigations

Recent developments from the U.S. Patent and Trademark Office (USPTO) have brought the doctrine of “settled expectations” into sharp focus. The acting director, Coke Morgan Stewart, has discretionarily denied several motions for inter partes review (IPR), invoking the reasoning that a patent owner accrues certain settled expectations when a patent has been active for six…

Read More

Litigation Trends 2025: Navigating Tech Patents, Cargo Losses, and Digital Currency Disputes

In the current landscape of legal disputes, several trends are capturing the attention of legal professionals worldwide. Among these, a notable surge in claims related to technology patents, cargo losses, and website currencies is redefining the focus in litigation. One of the most significant trends involves patents in the technology sector. Recently, the law firm…

Read More

NeoGenomics Triumphs in Patent Lawsuit Against Natera, Setting Precedent for Genetic Testing Innovations

In a significant development within the biotechnology sector, NeoGenomics Laboratories Inc. has successfully defended itself in a lawsuit brought by Natera Inc. The North Carolina federal court concluded that Natera’s claims of patent infringement concerning DNA cancer test technology were invalid. This ruling effectively dismisses the lawsuit against NeoGenomics, marking a notable moment in the…

Read More

Trump Signs Executive Order Stripping Federal Workers of Collective Bargaining Rights, Stirring Legal and Labor Concerns

In a recent development that has stirred significant controversy, President Donald Trump signed an executive order removing collective bargaining rights for federal workers at several agencies, including NASA, the National Weather Service, and the U.S. Patent and Trademark Office. This decision has drawn criticism from union representatives, who have described it as an act of…

Read More

U.S. Trade Agencies Oppose Masimo’s Legal Move Against Apple Watch Imports Amidst Patent Dispute

The legal standoff involving Masimo Corp. and Apple Inc. has taken a notable turn as the U.S. International Trade Commission (ITC) and U.S. Customs and Border Protection (CBP) challenged Masimo’s attempt to halt imports of Apple Watches. Masimo sought intervention from a D.C. federal court to temporarily block a ruling that permits the imports of…

Read More